Skip to main content

James Crowe Jr.

Study could lead to vaccine for mosquito-borne dengue virus

Jul. 9, 2015—Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.

Read more


Vanderbilt researchers develop potential treatment to fight mosquito-borne chikungunya virus

Jul. 8, 2015—In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States.

Read more


‘Redesigned’ antibodies may control HIV: study

May. 21, 2015—With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.

Read more


VU lands $9 million NIH grant to design better flu vaccines

May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.

Read more


VU joins national effort to speed Ebola therapy testing

Apr. 8, 2015—Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

Read more


Studies show human antibodies can fight lethal Marburg virus

Feb. 26, 2015—Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.

Read more


Core facilities key driver of VUMC research gains

Jan. 29, 2015—During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care.

Read more


VUCast: Why overweight women lose at work

Dec. 1, 2014—In the latest VUCast: Learn why overweight women lose in the workplace -- especially when it comes to pay; see breakthrough weapons in the fight against infectious diseases; and hear music legend Sheryl Crow speak about her craft. Watch now!

Read more


Ambassadors visit Vanderbilt, review research

Oct. 31, 2014—Ambassadors from 26 nations visited Vanderbilt Oct. 31 and heard from Chancellor Nicholas S. Zeppos and two researchers about their work.

Read more


Vanderbilt researchers isolate Ebola-fighting human antibodies for possible treatment

Oct. 28, 2014—Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.

Read more


Vanderbilt’s Brown, Crowe elected to IOM

Oct. 21, 2014—  Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization announced this week. With more than 1,900 active members and foreign associates, the IOM...

Read more


Alexander’s visit highlights efforts to confront Ebola

Sep. 24, 2014—Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

Read more


VIEW MORE EVENTS >